GSK1349572 Drug Interaction Study With Protease Inhibitors

NCT00774735 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Infection, Human Immunodeficiency Virus

Interventions

DRUG: GSK1349572
DRUG: GSK1349572

Sponsor

GlaxoSmithKline

Collaborators

[object Object]